The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)

Narayanaswamy Venketasubramanian, Chun Fan Lee, Ka Sing Wong, Christopher ChenJournal of Evidence-Based Medicine 2015 · DOI

Abstract

Patients who have moderately severe strokes and longer OTT demonstrate better treatment effects with MLC601. These factors can guide patient selection in future trials.
BibTeX
@article{venketasubramanian2015value,
  author = {Narayanaswamy Venketasubramanian and Chun Fan Lee and Ka Sing Wong and Christopher Chen},
  title = {{The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)}},
  journal = {Journal of Evidence-Based Medicine},
  year = {2015},
  doi = {10.1111/jebm.12170},
}

Loading related content...

Figure